1. Maxwell, Matthew B, Hom-Tedla, Marianne S, Yi, Jawoon, Kaech, Susan M, Hargreaves, Diana C. 2024. ARID1A suppresses R-loop-mediated STING-type I interferon pathway activation of anti-tumor immunity. In Cell, 187, 3390-3408.e19. doi:10.1016/j.cell.2024.04.025. https://pubmed.ncbi.nlm.nih.gov/38754421/
2. Liu, Anran, Ying, Songcheng. 2023. Aicardi-Goutières syndrome: A monogenic type I interferonopathy. In Scandinavian journal of immunology, 98, e13314. doi:10.1111/sji.13314. https://pubmed.ncbi.nlm.nih.gov/37515439/
3. Carmichael, Juliet, Figueiredo, Ines, Gurel, Bora, Sharp, Adam, de Bono, Johann. 2024. RNASEH2B loss and PARP inhibition in advanced prostate cancer. In The Journal of clinical investigation, 134, . doi:10.1172/JCI178278. https://pubmed.ncbi.nlm.nih.gov/38833311/
4. Briggs, Tracy A, Paul, Anindita, Rice, Gillian, Herrick, Ariane L. 2019. RNASEH2B Related Adult-Onset Interferonopathy. In Journal of clinical immunology, 39, 620-622. doi:10.1007/s10875-019-00673-w. https://pubmed.ncbi.nlm.nih.gov/31367981/
5. Spagnoli, Carlotta, Frattini, Daniele, Salerno, Grazia Gabriella, Fusco, Carlo. 2018. RNASEH2B Pathogenic Gene Variant in Uncomplicated Hereditary Spastic Paraplegia: Report of a New Patient. In Neuropediatrics, 49, 419. doi:10.1055/s-0038-1672174. https://pubmed.ncbi.nlm.nih.gov/30223285/
6. Miao, Chenkui, Tsujino, Takuya, Takai, Tomoaki, Kibel, Adam S, Jia, Li. 2022. RB1 loss overrides PARP inhibitor sensitivity driven by RNASEH2B loss in prostate cancer. In Science advances, 8, eabl9794. doi:10.1126/sciadv.abl9794. https://pubmed.ncbi.nlm.nih.gov/35179959/